You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 42794-0004


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 42794-0004

Drug NameNDCPrice/Unit ($)UnitDate
PROTRIPTYLINE HCL 5 MG TABLET 42794-0004-02 2.65134 EACH 2025-04-23
PROTRIPTYLINE HCL 5 MG TABLET 42794-0004-02 3.71785 EACH 2025-03-19
PROTRIPTYLINE HCL 5 MG TABLET 42794-0004-02 3.81785 EACH 2025-02-19
PROTRIPTYLINE HCL 5 MG TABLET 42794-0004-02 3.77138 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 42794-0004

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 42794-018

Introduction to NDC 42794-018

The National Drug Code (NDC) 42794-018 corresponds to the drug Liothyronine Sodium, a synthetic form of the thyroid hormone triiodothyronine. This medication is used to treat hypothyroidism and other thyroid-related conditions.

Drug Overview

  • Generic Name: Liothyronine Sodium
  • Dosage Form: Oral Tablet
  • Route of Administration: Oral
  • Marketing Start Date: December 3, 2012
  • Marketing Category: ANDA (Abbreviated New Drug Application)[5].

Market Dynamics

Current Market Status

Liothyronine Sodium, with the NDC 42794-018, is marketed by SIGMAPHARM LABORATORIES, LLC. As a generic drug, it competes in a market where multiple manufacturers produce similar formulations.

Pricing Trends

To analyze the pricing trends, we need to look at historical data and current market conditions. Here are some key points:

  • Price Variability: Prices for generic drugs can fluctuate based on market demand, production costs, and regulatory changes. For example, prices for other generic drugs have shown variability over time, such as the prices for PENTOXIFYLLINE ER 400 MG TAB, which ranged from $0.26913 to $0.34482 per unit over different dates in 2024[4].
  • Competition: The presence of multiple generic versions of Liothyronine Sodium can drive prices down due to competition. However, the specific pricing for NDC 42794-018 is not provided in the available sources.

Price Projections

Historical Context

While specific historical price data for NDC 42794-018 is not available, we can infer from general trends in the pharmaceutical industry:

  • Generic Drug Pricing: Generic drugs typically see a decrease in price over time due to increased competition and economies of scale in production.
  • Regulatory Impact: Changes in regulatory policies or the introduction of new generic versions can also impact pricing.

Future Projections

Based on industry trends and the nature of generic drugs:

  • Stable to Decreasing Prices: It is likely that the price of Liothyronine Sodium (NDC 42794-018) will remain stable or decrease slightly over the next few years due to ongoing competition and potential increases in production efficiency.
  • Market Forces: Any significant changes in demand or supply chain disruptions could impact prices, but these are generally short-term fluctuations.

Industry Trends and Predictions

Role of AI and Data Analytics

The pharmaceutical industry is increasingly leveraging artificial intelligence (AI) and data analytics to optimize operations, including pricing strategies. For instance, AI can help in predicting market demand and adjusting prices accordingly[3].

External Data and AI Models

The use of reliable external data to train internal data science models is becoming more prevalent. This trend could help pharmaceutical companies make more informed pricing decisions by analyzing broader market data and consumer behavior[3].

Key Takeaways

  • Drug Overview: Liothyronine Sodium (NDC 42794-018) is a generic thyroid hormone replacement medication.
  • Market Dynamics: The market for generic drugs is competitive, which can drive prices down.
  • Price Projections: Prices are likely to remain stable or decrease slightly due to competition and production efficiencies.
  • Industry Trends: The use of AI and data analytics is expected to play a significant role in pricing strategies.

FAQs

  1. What is the generic name of the drug with NDC 42794-018?

    • The generic name is Liothyronine Sodium.
  2. Who is the labeler for the drug NDC 42794-018?

    • The labeler is SIGMAPHARM LABORATORIES, LLC.
  3. What is the dosage form of Liothyronine Sodium (NDC 42794-018)?

    • The dosage form is an oral tablet.
  4. When did the marketing for Liothyronine Sodium (NDC 42794-018) start?

    • The marketing started on December 3, 2012.
  5. How might AI impact the pricing of generic drugs like Liothyronine Sodium?

    • AI can help in predicting market demand and optimizing pricing strategies by analyzing broader market data and consumer behavior.

Sources

  1. FDA Report on NDC 42794-018

  2. DrugPatentWatch - Latest Pharmaceutical Drug Prices and Trends

  3. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.